A 28-year-old Indian woman, 8 weeks pregnant, presents with persistent palpitations, anxiety, and a sleeping heart rate of 95 bpm. She was diagnosed with Graves' disease 2 years ago and was treated with antithyroid drugs (ATD) for 18 months, after which she achieved euthyroidism and the drugs were stopped. Her current TSH is 0.05 mIU/L (normal 0.4–4.0), free T4 is 2.1 pg/dL (normal 0.8–1.8), and free T3 is 4.8 pg/dL (normal 2.3–4.2). She is not on any medication currently. Which of the following is the most appropriate next step in management?

Explanation

## Management of Hyperthyroidism in Pregnancy ### Clinical Context This patient has **relapsed Graves' disease in pregnancy** with mild biochemical hyperthyroidism (suppressed TSH, mildly elevated free T4 and T3). The key challenge is balancing maternal and fetal safety. **Key Point:** Untreated or inadequately treated hyperthyroidism in pregnancy increases risk of: - Miscarriage - Preterm delivery - Intrauterine growth restriction - Neonatal thyrotoxicosis (if TRAb crosses placenta) - Maternal thyroid storm ### Why PTU (Not Methimazole) in Pregnancy | Drug | Mechanism | Pregnancy Issue | Recommendation | |------|-----------|-----------------|----------------| | **PTU** | Inhibits TPO + blocks T4→T3 conversion | Rare hepatotoxicity; minimal placental transfer | **First-line in 1st trimester** | | **Methimazole** | Inhibits TPO only | Methimazole embryopathy (rare but serious: esophageal atresia, choanal atresia) | Avoid in 1st trimester; acceptable 2nd/3rd | | **Propranolol** | β-blocker | Crosses placenta but safe in short courses; symptom control | **Adjunct for palpitations/anxiety** | | **Iodine (Lugol's)** | Inhibits hormone release | Crosses placenta; causes fetal goiter/hypothyroidism | Avoid in pregnancy | **High-Yield:** PTU is the drug of choice in the first trimester of pregnancy; methimazole is teratogenic. After first trimester, methimazole can be used due to lower hepatotoxicity risk. ### Correct Management Strategy 1. **Symptomatic control:** Propranolol 40 mg BD (β-blockers relieve palpitations, tremor, and anxiety without affecting thyroid function) 2. **Antithyroid therapy:** Start PTU at a dose to normalize free T4 (typically 50–100 mg TDS initially, then titrate down) 3. **Monitoring:** TSH and free T4 every 4 weeks; target free T4 in the upper-normal to mildly elevated range (to avoid overtreatment and fetal hypothyroidism) 4. **Avoid:** Methimazole (1st trimester), iodine, radioactive iodine, and thyroidectomy (unless ATD fails or severe adverse effects) **Clinical Pearl:** The goal in pregnancy is to use the *lowest effective dose* of PTU to keep free T4 in the high-normal range, accepting mild suppression of TSH. This minimizes fetal hypothyroidism risk from transplacental PTU passage. ### Why Not the Other Options **Propranolol alone** (option A says "propranolol + PTU," which is correct, but let me clarify): - Propranolol alone does not treat the underlying thyroid disorder - Must be combined with PTU for definitive control **Reassurance without treatment** (option B): - Suppressed TSH and elevated free T4 in pregnancy warrant treatment - Risk of fetal complications and maternal thyroid storm is real - Passive monitoring is inadequate **Methimazole** (option C): - Contraindicated in 1st trimester due to embryopathy risk - Patient is 8 weeks pregnant (within critical window) **Thyroidectomy** (option D): - Reserved for ATD intolerance/failure or patient preference - Not first-line in pregnancy - Carries surgical risk to mother and fetus